Benzinga | Jan 4, 2022 05:24AM EST

Piper Sandler Upgrades Globus Medical to Overweight, Raises Price Target to $88

Piper Sandler analyst Matt O'Brien upgrades Globus Medical (NYSE:GMED) from Neutral to Overweight and raises the price target from $80 to $88.